Study guide

2.2 Core Workflows and Decision Points

CEN Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: CEN Orientation and Exam Strategy

1.1 Current CEN Exam Facts 1.2 Eligibility, Application, and Scheduling 1.3 Blueprint Domains and Weighting 1.4 Question Style and Score Report Thinking 1.5 Study Calendar and Practice Plan

2 Chapter 2: Cardiovascular Disorders

2.1 Cardiovascular Disorders Overview 2.2 Core Workflows and Decision Points 2.3 Dysrhythmias, Cardiac Arrest, and ACLS 2.4 Shock, Vascular, and Pericardial Emergencies 2.5 Practice Drills and Readiness Markers

3 Chapter 3: Respiratory Disorders

3.1 Respiratory Disorders Overview 3.2 Core Workflows and Decision Points 3.3 Scenario Practice for Respiratory Disorders 3.4 Common Traps in Respiratory Disorders 3.5 Practice Drills and Readiness Markers

4 Chapter 4: Neurological Disorders

4.1 Neurological Disorders Overview 4.2 Core Workflows and Decision Points 4.3 Scenario Practice for Neurological Disorders 4.4 Common Traps in Neurological Disorders 4.5 Practice Drills and Readiness Markers

5 Chapter 5: Gastrointestinal Disorders

5.1 Gastrointestinal Disorders Overview 5.2 Core Workflows and Decision Points 5.3 Scenario Practice for Gastrointestinal Disorders 5.4 Common Traps in Gastrointestinal Disorders 5.5 Practice Drills and Readiness Markers

6 Chapter 6: Genitourinary, Gynecological, and Obstetrical Disorders

6.1 Genitourinary, Gynecological, and Obstetrical Disorders Overview 6.2 Genitourinary Emergencies: Infection, Obstruction, and the Scrotal Clock 6.3 Gynecologic Emergencies and Sexual-Assault Care 6.4 Obstetric Emergencies and Emergency Delivery 6.5 Practice Drills and Readiness Markers

7 Chapter 7: Mental Health Disorders

7.1 Mental Health Disorders Overview 7.2 Core Workflows and Decision Points 7.3 Scenario Practice for Mental Health Disorders 7.4 Common Traps in Mental Health Disorders 7.5 Practice Drills and Readiness Markers

8 Chapter 8: Medical Disorders

8.1 Medical Disorders Overview 8.2 Core Workflows and Decision Points 8.3 Scenario Practice for Medical Disorders 8.4 Common Traps in Medical Disorders 8.5 Practice Drills and Readiness Markers

9 Chapter 9: Musculoskeletal and Wound Disorders

9.1 Musculoskeletal and Wound Disorders Overview 9.2 Core Workflows and Decision Points 9.3 Scenario Practice for Musculoskeletal and Wound Disorders 9.4 Common Traps in Musculoskeletal and Wound Disorders 9.5 Practice Drills and Readiness Markers

10 Chapter 10: Head, Eye, Ear, Nose, and Throat Disorders

10.1 Head, Eye, Ear, Nose, and Throat Disorders Overview 10.2 Core Workflows and Decision Points 10.3 Scenario Practice for Head, Eye, Ear, Nose, and Throat Disorders 10.4 Common Traps in Head, Eye, Ear, Nose, and Throat Disorders 10.5 Practice Drills and Readiness Markers

11 Chapter 11: Environmental, Toxicological, and Communicable Disorders

11.1 Environmental, Toxicological, and Communicable Disorders Overview 11.2 Core Workflows and Decision Points 11.3 Scenario Practice for Environmental, Toxicological, and Communicable Disorders 11.4 Common Traps in Environmental, Toxicological, and Communicable Disorders 11.5 Practice Drills and Readiness Markers

12 Chapter 12: Professional Issues

12.1 Professional Issues Overview 12.2 Core Workflows and Decision Points 12.3 Scenario Practice for Professional Issues 12.4 Common Traps in Professional Issues 12.5 Practice Drills and Readiness Markers

13 Chapter 13: Final Review and Test Day

13.1 Timed Practice Strategy 13.2 Last-Week Review Map 13.3 Exam-Day Checklist 13.4 After the Exam and Next Steps

2.2 Core Workflows and Decision Points

Key Takeaways Explain This Topic AI

STEMI reperfusion is PCI within 90 minutes when available, or a fibrinolytic within 30 minutes (door-to-needle) when PCI is more than 120 minutes away.

Antiplatelet therapy with aspirin 162-325 mg chewed is given early in ACS unless contraindicated.

Nitroglycerin is contraindicated in right ventricular (inferior) MI and after recent phosphodiesterase inhibitor use because of severe preload-dependent hypotension.

Acute pulmonary edema is managed with upright positioning, oxygen/noninvasive ventilation, IV loop diuretics, and nitroglycerin to reduce preload and afterload.

Last updated: June 2026

The STEMI Reperfusion Decision

Once a STEMI is identified, the single most important workflow is choosing a reperfusion strategy :

Primary PCI (preferred): if the patient can reach a catheterization lab with a door-to-balloon time of 90 minutes or less , PCI is the gold standard. The emergency nurse activates the cath-lab team, continues monitoring, and prepares the patient.

Fibrinolytics: if PCI cannot be performed within about 120 minutes of first medical contact , give a fibrinolytic (alteplase, tenecteplase, or reteplase) with a door-to-needle time of 30 minutes or less , provided there are no contraindications.

Absolute fibrinolytic contraindications the CEN expects you to recognize include any prior intracranial hemorrhage , ischemic stroke within 3 months, known intracranial neoplasm or arteriovenous malformation, active internal bleeding, suspected aortic dissection , and significant closed-head trauma within 3 months. After thrombolytics, monitor closely for bleeding and for reperfusion dysrhythmias (an accelerated idioventricular rhythm is common and usually benign).

Initial ACS Drug Therapy

Beyond reperfusion, the early pharmacologic bundle for ACS is high-yield. A useful memory frame is the modernized version of "MONA," given in priority order rather than alphabetical order:

  • Drug Dose / detail CEN pearl
  • Aspirin 162-325 mg chewed First and most important; chewing speeds antiplatelet effect
  • Nitroglycerin 0.4 mg SL every 5 min x3 Reduces preload; check BP and rule out RV infarct first
  • Oxygen Titrate to SpO2 >= 90% Do NOT give routinely if SpO2 is normal
  • Morphine 2-4 mg IV for refractory pain Use cautiously; can mask symptoms and lower BP
  • P2Y12 inhibitor clopidogrel, ticagrelor, prasugrel Dual antiplatelet therapy with aspirin
  • Heparin Unfractionated or low-molecular-weight Anticoagulation per protocol

The nitroglycerin trap: nitroglycerin is contraindicated in right ventricular infarction (often accompanying an inferior STEMI, leads II/III/aVF) because the right ventricle is preload-dependent and nitrates cause profound hypotension. It is also contraindicated within 24-48 hours of phosphodiesterase-5 inhibitors (sildenafil, tadalafil). When an inferior MI is suspected, obtain right-sided leads (V4R) before giving nitrates.

Acute Heart Failure and Pulmonary Edema

Acute decompensated heart failure with flash pulmonary edema presents with severe dyspnea, orthopnea, pink frothy sputum, crackles, an S3 gallop, and hypoxia. The classic workflow targets preload, afterload, and oxygenation:

Position upright (high Fowler's, legs dependent) to reduce venous return.

Oxygenation: apply supplemental oxygen, and use noninvasive positive-pressure ventilation (CPAP or BiPAP) to improve oxygenation and decrease work of breathing and preload.

Loop diuretic: IV furosemide for fluid overload (onset within minutes IV).

Vasodilator: IV or sublingual nitroglycerin to reduce preload and afterload when blood pressure tolerates it; nitroprusside for severe hypertensive pulmonary edema.

Monitor B-type natriuretic peptide (BNP) ; a high BNP supports a cardiac cause of dyspnea.

The distinction the exam loves: in cardiogenic pulmonary edema the problem is pump failure and fluid backup, so you remove fluid and reduce afterload rather than give a bolus.

NSTEMI and Unstable Angina Workflow

Not every ACS goes to the cath lab in 90 minutes. NSTEMI and unstable angina are managed on a risk-stratified pathway rather than emergent reperfusion:

Give the same antiplatelet and anticoagulant therapy (aspirin, a P2Y12 inhibitor, heparin).

Add anti-ischemic therapy : nitroglycerin and a beta-blocker (if not contraindicated) to reduce myocardial oxygen demand.

High-risk NSTEMI patients (ongoing pain, dynamic ECG changes, rising troponin, hemodynamic instability) proceed to early invasive angiography , typically within 24 hours.

Lower-risk patients receive an ischemia-guided strategy with serial markers.

The key teaching point: a STEMI gets emergent reperfusion , while an NSTEMI gets urgent but not emergent catheterization. Fibrinolytics are used for STEMI only - they have no role in NSTEMI and can cause harm, which is a frequent distractor.

Beta-Blockers, Anticoagulation, and Monitoring

Early beta-blockade lowers heart rate, blood pressure, and contractility, reducing myocardial oxygen demand and infarct size. It is withheld in patients with signs of heart failure, cardiogenic shock, hypotension, bradycardia, or high-grade AV block - giving a beta-blocker to a patient sliding into cardiogenic shock can be fatal, a tested trap.

  • Therapy Purpose Hold/caution if
  • Beta-blocker Lower oxygen demand Heart failure, shock, bradycardia, AV block
  • Nitroglycerin Reduce preload/afterload RV infarct, SBP < 90, recent PDE-5 inhibitor
  • Heparin Prevent clot extension Active bleeding
  • Morphine Refractory pain Hypotension, respiratory depression

Throughout ACS care, watch for reperfusion dysrhythmias , recurrent chest pain (re-occlusion), and bleeding after antiplatelet, anticoagulant, or fibrinolytic therapy. Reassessment after each drug is the closed-loop habit the CEN rewards.

Right ventricular infarction management

When an inferior STEMI extends into the right ventricle, the management flips in an important way. Because the right ventricle is preload-dependent , these patients need volume , not preload reduction. The correct moves are to give IV fluids to support filling pressures and to withhold nitrates, diuretics, and morphine , all of which drop preload and can crash the blood pressure. If hypotension persists despite fluids, an inotrope such as dobutamine is added.

This is the mirror image of left-sided pump failure, where you remove fluid - and the CEN routinely places the two scenarios side by side to see whether you can tell a preload-dependent right-heart problem from fluid-overloaded left-heart failure.